Our platform technology immune “cloaks” human pluripotent stem cells and their adult derivatives enabling the development of true ‘off-the-shelf’ cell transplantation therapies.
Combined with an unparalleled expertise in generating stem cell-derived adult T, NK and B cells, Clade promises to become a leading innovator in developing widely accessible cell medicines.
The company is initially focused on harnessing the p...
Our platform technology immune “cloaks” human pluripotent stem cells and their adult derivatives enabling the development of true ‘off-the-shelf’ cell transplantation therapies.
Combined with an unparalleled expertise in generating stem cell-derived adult T, NK and B cells, Clade promises to become a leading innovator in developing widely accessible cell medicines.
The company is initially focused on harnessing the potential of “cloaked” immune cells for cancer treatment.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.